陈升鑫, 翟亚奇, 陈德鑫, 吴浪, 方开萱, 刘文静, 张贯军, 张大涯, 李明阳. 1型自身免疫性胰腺炎复发的相关危险因素研究[J]. 解放军医学院学报, 2023, 44(3): 220-224. DOI: 10.3969/j.issn.2095-5227.2023.03.003
引用本文: 陈升鑫, 翟亚奇, 陈德鑫, 吴浪, 方开萱, 刘文静, 张贯军, 张大涯, 李明阳. 1型自身免疫性胰腺炎复发的相关危险因素研究[J]. 解放军医学院学报, 2023, 44(3): 220-224. DOI: 10.3969/j.issn.2095-5227.2023.03.003
CHEN Shengxin, ZHAI Yaqi, CHEN Dexin, WU Lang, FANG Kaixuan, LIU Wenjing, ZHANG Guanjun, ZHANG Daya, LI Mingyang. Factors associated with recurrence of type 1 autoimmune pancreatitis[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(3): 220-224. DOI: 10.3969/j.issn.2095-5227.2023.03.003
Citation: CHEN Shengxin, ZHAI Yaqi, CHEN Dexin, WU Lang, FANG Kaixuan, LIU Wenjing, ZHANG Guanjun, ZHANG Daya, LI Mingyang. Factors associated with recurrence of type 1 autoimmune pancreatitis[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(3): 220-224. DOI: 10.3969/j.issn.2095-5227.2023.03.003

1型自身免疫性胰腺炎复发的相关危险因素研究

Factors associated with recurrence of type 1 autoimmune pancreatitis

  • 摘要:
      背景  自身免疫性胰腺炎(autoimmune pancreatitis,AIP)是一种良性高复发性特殊类型的胰腺炎,其复发相关的危险因素尚无定论。
      目的  探索1型自身免疫性胰腺炎复发的相关危险因素,旨在为临床诊疗提供依据。
      方法   回顾性分析2012 - 2020年解放军总医院收治的有完整随访资料的103例AIP患者临床资料,分析与复发相关的影响因素。
      结果  103例1型AIP患者中,男性79例,女性24例,平均年龄61.4 ± 10.6(范围:29 ~ 85)岁。中位随访时间为56(范围:24 ~ 128)个月,其中48.5%(50/103)的病例出现复发;单因素分析显示, 腮腺受累(P=0.032)、血清IgG4>1 140 mg/dL (P=0.014)、血清IgG>1 945 mg/dL (P=0.033)、血清γ球蛋白>26.9%(P=0.028)、维持治疗(P=0.005)在两组间的差异有统计学意义。多因素分析显示,血清IgG4>1 140 mg/dL(OR=2.156)、接受维持治疗(OR=0.642)等因素与1型AIP复发独立关联(P<0.05)。其中接受维持治疗是保护性因素。
      结论  初诊时血清IgG4>1 140 mg/dL是1型AIP复发的独立关联因素,而接受小剂量激素维持治疗能够减少复发。

     

    Abstract:
      Background  Autoimmune pancreatitis (AIP) is a special type of benign and highly recurrent pancreatitis, and its risk factors for recurrence have not been established.
      Objective  To explore the risk factors for recurrence of type 1 AIP, so as to raise the clinical awareness of diagnosis and treatment.
      Methods  Clinical data about 103 patients with AIP admitted to Chinese PLA General Hospital from 2012 to 2020 with complete follow-up data were retrospectively analyzed. Univariate and multivariate analysis were performed to find potential risk factors and protective factors for recurrence.
      Results  Of the 103 patients with type 1 AIP, 79 cases were male and 24 cases were female, with a mean age of 61.4 ± 10.6 (range: 29-85) years. The median follow-up was 56 (range: 24-128) months, with relapse occurring in 48.5% (50/103) of cases. Univariate analysis showed that parotid involvement (P=0.032), serum IgG4>1140 mg/dL (P=0.014), serum IgG>1 945 mg/dL (P=0.033), serum gamma globulin>26.9% (P=0.028), and maintenance treatment (P=0.005) had statistically significant differences between the two groups. Results of multifactorial analysis showed that serum IgG4>1140 mg/dL (OR=2.156), receiving maintenance therapy (OR=0.642) were independently associated with type 1 AIP recurrence (P<0.05). Among them, receiving maintenance therapy was a protective factor.
      Conclusion  Serum IgG4>1 140 mg/dL at diagnosis is an independent risk factor for recurrence of type 1 AIP, and low-dose glucocorticoids maintenance therapy can reduce recurrence.

     

/

返回文章
返回